Legorreta Pablo G. Transaction History

Date Transaction Value Shares Traded Form
Jun 28 2023
BUY
Open market or private purchase
$3,836,300 $29.51 p/Share
130,000
Jun 13 2023
BUY
Open market or private purchase
$1,475,100 $32.78 p/Share
45,000
Jun 12 2023
BUY
Open market or private purchase
$1,485,000 $33.0 p/Share
45,000
May 24 2023
BUY
Open market or private purchase
$4,837,500 $32.25 p/Share
150,000
May 17 2023
BUY
Open market or private purchase
$2,293,019 $32.94 p/Share
69,612
May 16 2023
BUY
Open market or private purchase
$5,384,225 $33.57 p/Share
160,388
Dec 30 2022
BUY
Bona fide gift
-
292,190
Apr 14 2022
SELL
Other acquisition or disposition
-
462,031
May 07 2021
BUY
Conversion of derivative security
-
2,325,000
Oct 20 2020
BUY
Conversion of derivative security
-
428,420
Jun 18 2020
BUY
Conversion of derivative security
-
241,810
Jun 18 2020
BUY
Open market or private purchase
$560,000 $28.0 p/Share
20,000
Jun 16 2020
BUY
Conversion of derivative security
-
493,750

Also insider at

EPZM
Epizyme, Inc. Healthcare
DNAC
Social Capital Suvretta Holdings Corp. III
LPG

Legorreta Pablo G.

CEO, Chairman of the Board
Winston Salem, NC

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if

News

Receive news related to Royalty Pharma plc

Track Activities on RPRX